# Sirtuins Contribute to the Migraine–Stroke Connection

**Authors:** Jan Krekora, Michal Fila, Maria Mitus-Kenig, Elzbieta Pawlowska, Justyna Ciupinska, Janusz Blasiak

PMC · DOI: 10.3390/ijms26146634 · International Journal of Molecular Sciences · 2025-07-10

## TL;DR

This paper explores how sirtuins, a group of proteins, may connect migraines and strokes through shared biological mechanisms.

## Contribution

The paper proposes sirtuins as a novel link between migraines and strokes, suggesting their role in antioxidant defense and mitochondrial function.

## Key findings

- Sirtuins are involved in antioxidant defense, which is crucial in both migraine and stroke pathogenesis.
- Mitochondrial sirtuins (SIRT2, SIRT3, SIRT4) help manage oxidative stress, a key factor in migraine and stroke.
- Sirtuins may serve as therapeutic targets to treat migraines and prevent strokes.

## Abstract

The prevalence of stroke in patients with migraine is higher than in the general population, suggesting certain shared mechanisms of pathogenesis. Migrainous infarction is a pronounced example of the migraine–stroke connection. Some cases of migraine with aura may be misdiagnosed as stroke, with subsequent mistreatment. Therefore, it is important to identify these shared mechanisms of pathogenesis contributing to the migraine–stroke connection to improve diagnosis and treatment. Sirtuins (SIRTs) are a seven-member family of NAD+-dependent histone deacetylases that can epigenetically regulate gene expression. Sirtuins possess antioxidant properties, making them a first-line defense against oxidative stress, which is important in the pathogenesis of migraine and stroke. Mitochondrial localization of SIRT2, SIRT3, and SIRT4 supports this function, as most reactive oxygen and nitrogen species are produced in mitochondria. In this narrative review, we present arguments that sirtuins may link migraine with stroke through their involvement in antioxidant defense, mitochondrial quality control, neuroinflammation, and autophagy. We also indicate mediators of this involvement that can be, along with sirtuins, therapeutic targets to ameliorate migraine and prevent stroke.

## Linked entities

- **Genes:** SIRT2 (sirtuin 2) [NCBI Gene 22933], SIRT3 (sirtuin 3) [NCBI Gene 23410], SIRT4 (sirtuin 4) [NCBI Gene 23409]
- **Diseases:** migraine (MONDO:0005277), stroke (MONDO:0005098)

## Full-text entities

- **Genes:** SIRT4 (sirtuin 4) [NCBI Gene 23409] {aka SIR2L4}, SIRT2 (sirtuin 2) [NCBI Gene 22933] {aka SIR2, SIR2L, SIR2L2}, SIRT3 (sirtuin 3) [NCBI Gene 23410] {aka SIR2L3}
- **Diseases:** Migraine (MESH:D008881), Stroke (MESH:D020521), Migrainous infarction (MESH:D007238), neuroinflammation (MESH:D000090862), migraine with aura (MESH:D020325)
- **Chemicals:** reactive oxygen and nitrogen species (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12294337/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12294337/full.md

## References

141 references — full list in the complete paper: https://tomesphere.com/paper/PMC12294337/full.md

---
Source: https://tomesphere.com/paper/PMC12294337